(株)日本エム・ディ・エム
株価チャート
2026/08/21 更新株価トレンド
2026/08/21 更新株価・取引詳細
2026/08/21 更新株価
取引
株主構成
2026/08/01 更新大株主
2026/08/01 更新| 機関名 | 保有比率 | 保有株数 | 変化 |
|---|---|---|---|
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
57.4K | 0.00% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
26.3K | +3.11% | |
|
Dimensional ETF Trust-Dimensional International Small Cap ETF
|
27.2K | +12.40% | |
|
Dimensional ETF Trust-Dimensional International Core Equity 2 ETF
|
25.1K | 0.00% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
19.9K | -27.94% | |
|
SEI INSTITUTIONAL INVESTMENTS TRUST-SIIT World Equity EX-US Fund
|
20.0K | 0.00% |
配当履歴 4年連続増配
2026/08/23 更新| 年度 | 配当金 | 変化 |
|---|---|---|
| 2026 | ¥17 | +13.3% |
| 2025 | ¥15 | +7.1% |
| 2024 | ¥14 | +7.7% |
| 2023 | ¥13 | +8.3% |
| 2022 | ¥12 | - |
財務パフォーマンス
2026/08/23 更新売上・利益
利益率
キャッシュフロー
財務健全性
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| 損益計算書 | ||||
| 売上高 | ¥213億 | ¥232億 | ¥251億 | ¥239億 |
| 売上総利益 | ¥140億 | ¥148億 | ¥156億 | ¥141億 |
| 営業利益 | ¥20億 | ¥17億 | ¥16億 | ¥6億 |
| 経常利益 | ¥18億 | ¥17億 | -¥3億 | ¥7億 |
| 当期純利益 | ¥14億 | ¥13億 | -¥5億 | ¥3億 |
| EPS | ¥54.03 | ¥48.31 | -¥17.50 | ¥9.99 |
| 営業利益率 | 9.50% | 7.54% | 6.20% | 2.40% |
| 貸借対照表 | ||||
| 総資産 | ¥294億 | ¥315億 | ¥337億 | ¥357億 |
| 純資産 | ¥232億 | ¥255億 | ¥247億 | ¥254億 |
| 総負債 | ¥63億 | ¥60億 | ¥90億 | ¥103億 |
| 現金 | ¥28億 | ¥23億 | ¥32億 | ¥31億 |
| 有利子負債 | ¥19億 | ¥15億 | ¥33億 | ¥59億 |
| 自己資本比率 | 78.69% | 81.02% | 73.30% | 71.19% |
| D/Eレシオ | 0.08 | 0.06 | 0.13 | 0.23 |
| キャッシュフロー | ||||
| 営業CF | ¥22億 | ¥21億 | ¥10億 | ¥2億 |
| 投資CF | -¥15億 | -¥18億 | -¥17億 | -¥20億 |
| 財務CF | -¥5億 | -¥8億 | ¥15億 | ¥16億 |
| フリーCF | ¥9億 | ¥3億 | -¥6億 | -¥18億 |
| 効率性 | ||||
| ROE | 6.15% | 4.98% | -1.87% | 1.04% |
| ROA | 4.84% | 4.04% | -1.37% | 0.74% |
最新IR情報
最新ニュース (5件)
株価|Web東奥 - 東奥日報社 ↗
マーケット速報 - nnn.co.jp ↗
日本MDM、4-6月期(1Q)経常は赤字転落で着地 - 株探 ↗
企業情報
会社概要
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site used in surgery to treat femoral neck fractures, most often suffered by the elderly, and other fractures from auto-related and other accidents; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury, such as hip and knee joint products; spinal fixation devices to fix spinal instability directly through corrective surgery; and artificial bones that are used to fill gaps in bone defects caused by bone fractures or bone tumors. It offers its products to doctors, medical institutions, and hospitals. The company was incorporated in 1973 and is headquartered in Shinjuku, Japan.